What is Zacks Research's Estimate for SBC Q1 Earnings?

Key Points

• Zacks Research analyst M. Marin forecasts SBC will report $0.09 EPS for Q1 2026 and projects quarterly EPS of $0.12 (Q2), $0.13 (Q3), $0.12 (Q4) for a $0.46 FY2026 total.
• In its most recent quarter SBC reported $0.14 EPS, beating consensus by $0.01, while revenue of $39.57 million missed the $45.19 million estimate.
• CEO Yoshiyuki Aikawa sold 4,422,900 shares for about $9,376,548, reducing his ownership by 83.7%, and corporate insiders now own 89.47% of the company.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Zacks Research issued their Q1 2026 earnings per share estimates for SBC Medical Group in a report issued on Monday, April 6th. Zacks Research analyst M. Marin forecasts that the company will post earnings of $0.09 per share for the quarter. The consensus estimate for SBC Medical Group's current full-year earnings is $5.02 per share. Zacks Research also issued estimates for SBC Medical Group's Q2 2026 earnings at $0.12 EPS, Q3 2026 earnings at $0.13 EPS, Q4 2026 earnings at $0.12 EPS and FY2026 earnings at $0.46 EPS.

A number of other analysts also recently weighed in on SBC. Weiss Ratings restated a "sell (d+)" rating on shares of SBC Medical Group in a research note on Friday, March 27th. BTIG Research began coverage on SBC Medical Group in a research note on Friday, March 6th. They issued a "buy" rating and a $8.00 price target on the stock. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $8.50.

SBC Medical Group Stock Up 1.3%

SBC Medical Group stock opened at $4.53 on Tuesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 3.78 and a quick ratio of 5.06. SBC Medical Group has a 1-year low of $2.97 and a 1-year high of $5.75. The company has a market cap of $464.69 million, a PE ratio of 9.24 and a beta of 0.99. The stock's 50 day moving average price is $4.13 and its 200 day moving average price is $4.03.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last posted its quarterly earnings results on Friday, March 27th. The company reported $0.14 earnings per share for the quarter, beating analysts' consensus estimates of $0.13 by $0.01. SBC Medical Group had a return on equity of 20.76% and a net margin of 29.37%.The firm had revenue of $39.57 million for the quarter, compared to the consensus estimate of $45.19 million.

Hedge Funds Weigh In On SBC Medical Group

Several hedge funds and other institutional investors have recently bought and sold shares of SBC. Goldman Sachs Group Inc. acquired a new position in shares of SBC Medical Group in the fourth quarter worth $49,000. Russell Investments Group Ltd. raised its holdings in shares of SBC Medical Group by 292.0% in the fourth quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company's stock worth $51,000 after acquiring an additional 8,771 shares during the last quarter. Nuveen LLC acquired a new position in shares of SBC Medical Group in the fourth quarter worth $53,000. Wells Fargo & Company MN raised its holdings in shares of SBC Medical Group by 195.1% in the fourth quarter. Wells Fargo & Company MN now owns 12,626 shares of the company's stock worth $54,000 after acquiring an additional 8,348 shares during the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of SBC Medical Group in the second quarter worth $64,000. 60.82% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at SBC Medical Group

In related news, CEO Yoshiyuki Aikawa sold 4,422,900 shares of SBC Medical Group stock in a transaction on Friday, March 6th. The stock was sold at an average price of $2.12, for a total transaction of $9,376,548.00. Following the completion of the transaction, the chief executive officer directly owned 861,600 shares of the company's stock, valued at approximately $1,826,592. The trade was a 83.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 89.47% of the company's stock.

About SBC Medical Group

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company's primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.